Loading
Michele Oshman

Michele Oshman

Chief Patient Advocate and Head, Patient Advocacy Center of Excellence, Biotechnology Innovation Organization (BIO)
United States
Michele M. Oshman is Chief Patient Advocate and Head of Alliance Development at the Biotechnology Innovation Organization (BIO). BIO is the premier biotechnology advocacy organization representing biotech companies, industry leaders, and state biotech associations in the United States and more than 35 countries around the globe. BIO members range from biotech start-ups to some of the world’s largest biopharmaceutical companies – all united by the same goal: to develop medical and scientific breakthroughs that prevent and fight disease, restore health, and improve patients’ lives. In her role, she leads an incredibly strong patient advocacy team, where she oversees BIO’s engagement with patient advocacy and other key stakeholder communities, drives support for members’ patient engagement and patient advocacy work, and ensures BIO’s policies reflect patient perspectives. Ms. Oshman joined BIO in January 2020 after a successful 18-year career at Eli Lilly and Company, where she led federal alliance development outreach. She served in multiple clinical development, patient advocacy and corporate leadership roles, earning a Six Sigma Black Belt, and leading multiple transformational efforts across the company. Ms. Oshman serves on the Board of Directors for the National Health Council (NHC). Created by and for patient organizations more than 100 years ago, NHC brings together over 160 national health-related organizations and businesses, including 100 patient advocacy groups. NHC drives drive patient-centered health policy and promotes access to affordable, high-value, and equitable health care. She is serving her second term on the Board of the American Brain Coalition, a non-profit organization comprised of professional and academic organizations focused on brain health. In 2023, she was elected to Health On Wednesday, a women’s organization whose membership is limited to 45 executive health policy leaders. Ms. Oshman also serves on the prestigious Committee on Nominations and Leadership Development for the American Association for the Advancement of Science (AAAS). An active member of the Japan America Society of Washington DC, Ms. Oshman graduated from American University with a dual degree in Political Science and Communications. She has two wonderful children, a loving husband of over 26 years, an oversized Akita, and a very small house.

Sessions